PlexusDx customers can access their medication records and compounding details through the patient portal
Pseudohyperkalemia, an artificially high potassium level, occurs due to a mechanical release of intracellular potassium during sample collection or processing due to hemolysis [11,43]
In a phase 2 trial of obese subjects, cagrilintide used in different subcutaneous doses once weekly was associated with a mean weight loss of 6-10.8% after 26 weeks, compared with 9.0% with the glucagon-like 1 receptor (GLP-1R) liraglutide (3 mg/d) and 3% with placebo at 26 weeks
[26] heterosynaptic depression is thought to be linked to the release of adenosine triphosphate (ATP) from astrocytes
Ask LIV Body how its pharmacy network is structured relative to this proposal and what its continuity plan is if the proposal is finalized
CrossRef Beyond Discrete Diagnoses: Conceptualizing Obesity-associated Metabolic Disorders as a Unified, Dynamic Continuum Cong Xie, Yulian Yuan, Yunjing Wang, Cong Qi, Wei Wang, Chuan An, Aifeila Aikepaer, Yaofu Zhang, Ge Zhang, Xingzhong Feng, Huijuan Gao Current Obesity Reports .2025;[Epub] CrossRef Immunotherapy versus lenvatinib in advanced hepatocellular carcinoma: The critical role of subgroup analyses Tingfeng Huang, Jia-Hao Law, Ningqi Pang, Shichuan Tang iLIVER .2025
